apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

Fortgeschrittenes Prostatakarzinom: Sequenz aus androgenrezeptorgerichteten Substanzen und Chemotherapie entscheidet über das Langzeitüberleben (2021) Wuelfing C, Goebell P, Eichenauer R, Lange C, Machtens S, Schwentner C, Todenhoefer T, et al. Journal article Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials (2021) Burdett S, Fisher DJ, Vale CL, Bono AV, Clarke NW, Cognetti F, Collette L, et al. Journal article, Review article Rational follow-up of non-muscle invasive bladder cancer Rationale Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms (2021) Von Landenberg N, Benderska-Soeder N, Bismarck E, Kernig K, Erne E, Goebell P, Schmitz-Draeger BJ Journal article, Review article Real-world treatment patterns in metastatic hormone-sensitive prostate cancer (mHSPC) patients in the US, Germany, France, China and Japan (2021) Goebell P, Shah R, Raina R, Rege S, Chen SL, Lee VE, Waldeck R Conference contribution Was machen Urologen in der Praxis? Ein erster „ungefilterter“ Blick auf die Versorgung (2021) Goebell P, El-Khadra S, Horstmann M, Kollenbach P, Luedecke G, Quack T, Rug M, et al. Journal article, Review article Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project (2021) Wang G, Black PC, Goebell P, Ji L, Cordon-Cardo C, Schmitz-Dräger B, Hawes D, et al. Journal article Assessment of prognosis by established prognosis scores and physicians' judgement in mRCC patients: an analysis of the STAR-TOR registry (2020) Boegemann M, Goebell P, Woike M, Buncke J, Schlack K, Schrader AJ Journal article Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial (2020) Staehler M, Stoeckle M, Christoph DC, Stenzl A, Potthoff K, Grimm MO, Klein D, et al. Journal article Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma (2020) Goebell P, Ivanyi P, Bedke J, Bergmann L, Berthold D, Boegemann M, Busch J, et al. Journal article, Review article Aktuelle Systemtherapie beim Nierenzellkarzinom (2020) Goebell P Journal article